These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Studies on some aspects of the neuropharmacology of butylurea. Dar MS; Fakouhi T Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473 [No Abstract] [Full Text] [Related]
6. Effects of DDT and of drug-DDT interactions on electroshock seizures in the rat. Woolley DE Toxicol Appl Pharmacol; 1970 Mar; 16(2):521-32. PubMed ID: 5435619 [No Abstract] [Full Text] [Related]
7. [Application of sleep induced in the rat by sudden change in the environmental temperature to the study of antagonism between neurostimulants and hypnotics]. Streichenberger G; Lechat P Med Pharmacol Exp Int J Exp Med; 1967; 17(3):214-20. PubMed ID: 4384811 [No Abstract] [Full Text] [Related]
8. The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system. Suchowsky GK; Pegrassi L Arzneimittelforschung; 1969 Apr; 19(4):643-8. PubMed ID: 4977576 [No Abstract] [Full Text] [Related]
9. Compounds affecting the central nervous system. V. Substituted 3-dialkylaminoalkylindenes. Bavin PM; Ganellin CR; Loynes JM; Spickett RG J Med Chem; 1969 May; 12(3):513-6. PubMed ID: 5815189 [No Abstract] [Full Text] [Related]
10. [Effect of alkyl derivatives of cysteamine and cystamine and some aminoalkyldisulfides on central nervous system]. Smaĭlene AA; Slavachevskaia NM Farmakol Toksikol; 1970; 33(3):271-5. PubMed ID: 4393830 [No Abstract] [Full Text] [Related]
11. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol]. Avakumov VM; Batulin IuM Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126 [No Abstract] [Full Text] [Related]
12. The influence of substituted derivatives of phenyldiallylacetamide on the central nervous system. Zak A; Prastowski W Arch Immunol Ther Exp (Warsz); 1966; 14(5):657-61. PubMed ID: 5923830 [No Abstract] [Full Text] [Related]
13. [Demonstration of a depressive component in the central effects of nikethamide]. Buchel L; Absil J Arch Sci Physiol (Paris); 1972; 26(2):175-94. PubMed ID: 4265482 [No Abstract] [Full Text] [Related]
14. [Research on various sulfonacyl-hydrazine and sulfonhydrazine derivatives]. Cuparencu B; Safta L; Ariesan V; Pitea M; Marie A Therapie; 1972; 27(2):309-23. PubMed ID: 5084675 [No Abstract] [Full Text] [Related]
15. A study of the central action of flurothyl and methoxyflurane. Schuck SL; Shulman A Aust J Exp Biol Med Sci; 1971 Oct; 49(5):501-2. PubMed ID: 4400855 [No Abstract] [Full Text] [Related]
16. [Pharmacology of derivatives with oxime function: 2-hydroxy-3-methoxy-benzaldoxime]. Pham-Huu-Chanh ; Chanvattey S; Azum-Gelade MC; Silve-Mamy G Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):443-58. PubMed ID: 4391898 [No Abstract] [Full Text] [Related]
17. [Simple methods for the pharmacologic differentiation of central muscle relaxants]. Hofrichter G; Roesch A; Roesch E; Schenk G Arzneimittelforschung; 1967 Feb; 17(2):242-5. PubMed ID: 5631491 [No Abstract] [Full Text] [Related]
18. Action of central nervous system stimulant and depressant drugs in the intact animal. 3. Dual action of 5-ethyl-5-(1,3-dimethylbutyl)barbiturate, dilantin and beta-methyl-beta-eta-propylglutarimide. Shulman A; Laycock GM Eur J Pharmacol; 1967 Oct; 2(1):17-25. PubMed ID: 4384752 [No Abstract] [Full Text] [Related]
19. Effect of p-chlorophenylalanine on the central nervous excitability threshold and on the activity of some central depressants. Georgiev VP; Petkova BP Med Biol; 1975 Feb; 53(1):47-50. PubMed ID: 124805 [TBL] [Abstract][Full Text] [Related]